BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Dou D, Yang S, Lin Y, Zhang J. An eight-miRNA signature expression-based risk scoring system for prediction of survival in pancreatic adenocarcinoma. Cancer Biomark 2018;23:79-93. [PMID: 29991127 DOI: 10.3233/CBM-181420] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
Number Citing Articles
1 Chen X, Yang J, Lu Z, Ding Y. A 70‑RNA model based on SVR and RFE for predicting the pancreatic cancer clinical prognosis. Methods 2022. [DOI: 10.1016/j.ymeth.2022.02.011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Gong X, Liu Y, Zheng C, Tian P, Peng M, Pan Y, Li X. Establishment of a 4-miRNA Prognostic Model for Risk Stratification of Patients With Pancreatic Adenocarcinoma. Front Oncol 2022;12:827259. [PMID: 35186758 DOI: 10.3389/fonc.2022.827259] [Reference Citation Analysis]
3 Wu Y, Shen Q, Chen X, Wu Y, Niu Y, Lv F. miR-1301-3p promotes the proliferation and migration of lung cancer cells via direct repression of polymerase I and transcript release factor. Oncol Lett 2020;20:286. [PMID: 33014164 DOI: 10.3892/ol.2020.12149] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
4 Zhou Z, Zhou X, Jiang Y, Qiu M, Liang X, Lin Q, Guo Q, Nong C, Huo R, Chen Q, Liu H, Liu Y, Zhu S, Wang M, Yu H. Clinical significance of miR-1180-3p in hepatocellular carcinoma: a study based on bioinformatics analysis and RT-qPCR validation. Sci Rep 2020;10:11573. [PMID: 32665670 DOI: 10.1038/s41598-020-68450-z] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
5 Bai X, Lu D, Lin Y, Lv Y, He L. A seven-miRNA expression-based prognostic signature and its corresponding potential competing endogenous RNA network in early pancreatic cancer. Exp Ther Med 2019;18:1601-8. [PMID: 31410115 DOI: 10.3892/etm.2019.7728] [Cited by in Crossref: 5] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
6 Su Q, Zhu EC, Qu YL, Wang DY, Qu WW, Zhang CG, Wu T, Gao ZH. Serum level of co-expressed hub miRNAs as diagnostic and prognostic biomarkers for pancreatic ductal adenocarcinoma. J Cancer 2018;9:3991-9. [PMID: 30410604 DOI: 10.7150/jca.27697] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 4.3] [Reference Citation Analysis]
7 Dhayat SA, Traeger MM, Rehkaemper J, Stroese AJ, Steinestel K, Wardelmann E, Kabar I, Senninger N. Clinical Impact of Epithelial-to-Mesenchymal Transition Regulating MicroRNAs in Pancreatic Ductal Adenocarcinoma. Cancers (Basel) 2018;10:E328. [PMID: 30217058 DOI: 10.3390/cancers10090328] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]